Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Interstitial microRNA miR-214 attenuates inflammation and polycystic kidney disease progression.

Lakhia R, Yheskel M, Flaten A, Ramalingam H, Aboudehen K, Ferrè S, Biggers LM, Mishra A, Chaney CP, Wallace DP, Carroll T, Igarashi P, Patel V.

JCI Insight. 2020 Mar 17. pii: 133785. doi: 10.1172/jci.insight.133785. [Epub ahead of print]

2.

A high-throughput screening platform for Polycystic Kidney Disease (PKD) drug repurposing utilizing murine and human ADPKD cells.

Asawa RR, Danchik C, Zahkarov A, Chen Y, Voss T, Jadhav A, Wallace DP, Trott JF, Weiss RH, Simeonov A, Martinez NJ.

Sci Rep. 2020 Mar 6;10(1):4203. doi: 10.1038/s41598-020-61082-3.

3.

Dietary phosphate restriction attenuates polycystic kidney disease in mice.

Omede F, Zhang S, Johnson C, Daniel E, Zhang Y, Fields TA, Boulanger J, Liu S, Ahmed I, Umar S, Wallace DP, Stubbs JR.

Am J Physiol Renal Physiol. 2020 Jan 1;318(1):F35-F42. doi: 10.1152/ajprenal.00282.2019. Epub 2019 Nov 4.

PMID:
31682174
4.

In vitro cyst formation of ADPKD cells.

Sharma M, Reif GA, Wallace DP.

Methods Cell Biol. 2019;153:93-111. doi: 10.1016/bs.mcb.2019.05.008. Epub 2019 Jun 13.

PMID:
31395386
5.

ADPKD cell proliferation and Cl--dependent fluid secretion.

Reif GA, Wallace DP.

Methods Cell Biol. 2019;153:69-92. doi: 10.1016/bs.mcb.2019.06.001. Epub 2019 Jul 17.

PMID:
31395385
6.

Generation of primary cells from ADPKD and normal human kidneys.

Wallace DP, Reif GA.

Methods Cell Biol. 2019;153:1-23. doi: 10.1016/bs.mcb.2019.05.005. Epub 2019 Jun 13.

PMID:
31395374
7.

MCP-1 promotes detrimental cardiac physiology, pulmonary edema, and death in the cpk model of polycystic kidney disease.

Salah SM, Meisenheimer JD, Rao R, Peda JD, Wallace DP, Foster D, Li X, Li X, Zhou X, Vallejo JA, Wacker MJ, Fields TA, Swenson-Fields KI.

Am J Physiol Renal Physiol. 2019 Aug 1;317(2):F343-F360. doi: 10.1152/ajprenal.00240.2018. Epub 2019 May 15.

PMID:
31091126
8.

Polycystin 2 regulates mitochondrial Ca2+ signaling, bioenergetics, and dynamics through mitofusin 2.

Kuo IY, Brill AL, Lemos FO, Jiang JY, Falcone JL, Kimmerling EP, Cai Y, Dong K, Kaplan DL, Wallace DP, Hofer AM, Ehrlich BE.

Sci Signal. 2019 May 7;12(580). pii: eaat7397. doi: 10.1126/scisignal.aat7397.

9.

Periostin in the Kidney.

Wallace DP.

Adv Exp Med Biol. 2019;1132:99-112. doi: 10.1007/978-981-13-6657-4_11. Review.

PMID:
31037629
10.

Parent psychological flexibility in the context of pediatric pain: Brief assessment and associations with parent behaviour and child functioning.

Timmers I, Simons LE, Hernandez JM, McCracken LM, Wallace DP.

Eur J Pain. 2019 Aug;23(7):1340-1350. doi: 10.1002/ejp.1403. Epub 2019 May 14.

PMID:
31002473
11.

Periostin overexpression in collecting ducts accelerates renal cyst growth and fibrosis in polycystic kidney disease.

Raman A, Parnell SC, Zhang Y, Reif GA, Dai Y, Khanna A, Daniel E, White C, Vivian JL, Wallace DP.

Am J Physiol Renal Physiol. 2018 Dec 1;315(6):F1695-F1707. doi: 10.1152/ajprenal.00246.2018. Epub 2018 Oct 17.

12.

Human-Specific Abnormal Alternative Splicing of Wild-Type PKD1 Induces Premature Termination of Polycystin-1.

Lea WA, Parnell SC, Wallace DP, Calvet JP, Zelenchuk LV, Alvarez NS, Ward CJ.

J Am Soc Nephrol. 2018 Oct;29(10):2482-2492. doi: 10.1681/ASN.2018040442. Epub 2018 Sep 5.

13.

Early pregnancy loss in Belagavi, Karnataka, India 2014-2017: a prospective population-based observational study in a low-resource setting.

Dhaded SM, Somannavar MS, Jacob JP, McClure EM, Vernekar SS, Yogesh Kumar S, Kavi A, Ramadurg UY, Moore JL, Wallace DP, Derman RJ, Goldenberg RL, Goudar SS.

Reprod Health. 2018 Jun 22;15(Suppl 1):95. doi: 10.1186/s12978-018-0525-4.

14.

Neuropsychological Functioning of Youth Receiving Intensive Interdisciplinary Pain Treatment.

Low Kapalu CM, Hall JJ, Wallace DP.

J Pediatr Psychol. 2018 Sep 1;43(8):870-881. doi: 10.1093/jpepsy/jsy034.

PMID:
29846679
15.

Parent Responses to Child Pain During Intensive Interdisciplinary Pain Treatment and 1-Year Follow-Up.

Pielech M, Wallace DP, Fitzgerald M, Hoffart CM.

J Pain. 2018 Nov;19(11):1275-1284. doi: 10.1016/j.jpain.2018.05.002. Epub 2018 May 17.

PMID:
29777954
16.

Inhibition of Hedgehog signaling suppresses proliferation and microcyst formation of human Autosomal Dominant Polycystic Kidney Disease cells.

Silva LM, Jacobs DT, Allard BA, Fields TA, Sharma M, Wallace DP, Tran PV.

Sci Rep. 2018 Mar 21;8(1):4985. doi: 10.1038/s41598-018-23341-2.

17.

Deficient transient receptor potential vanilloid type 4 function contributes to compromised [Ca2+]i homeostasis in human autosomal-dominant polycystic kidney disease cells.

Tomilin V, Reif GA, Zaika O, Wallace DP, Pochynyuk O.

FASEB J. 2018 Aug;32(8):4612-4623. doi: 10.1096/fj.201701535RR. Epub 2018 Mar 19.

18.

Aberrant Regulation of Notch3 Signaling Pathway in Polycystic Kidney Disease.

Idowu J, Home T, Patel N, Magenheimer B, Tran PV, Maser RL, Ward CJ, Calvet JP, Wallace DP, Sharma M.

Sci Rep. 2018 Feb 20;8(1):3340. doi: 10.1038/s41598-018-21132-3.

19.

Increased YAP Activation Is Associated With Hepatic Cyst Epithelial Cell Proliferation in ARPKD/CHF.

Jiang L, Sun L, Edwards G, Manley M Jr, Wallace DP, Septer S, Manohar C, Pritchard MT, Apte U.

Gene Expr. 2017 Nov 27;17(4):313-326. doi: 10.3727/105221617X15034976037343. Epub 2017 Sep 15.

20.

Insights into cellular and molecular basis for urinary tract infection in autosomal-dominant polycystic kidney disease.

Gao C, Zhang L, Zhang Y, Wallace DP, Lopez-Soler RI, Higgins PJ, Zhang W.

Am J Physiol Renal Physiol. 2017 Nov 1;313(5):F1077-F1083. doi: 10.1152/ajprenal.00279.2017. Epub 2017 Aug 9. Review.

21.

Integrin-Linked Kinase Signaling Promotes Cyst Growth and Fibrosis in Polycystic Kidney Disease.

Raman A, Reif GA, Dai Y, Khanna A, Li X, Astleford L, Parnell SC, Calvet JP, Wallace DP.

J Am Soc Nephrol. 2017 Sep;28(9):2708-2719. doi: 10.1681/ASN.2016111235. Epub 2017 May 18.

22.
23.

Ouabain promotes partial epithelial to mesenchymal transition (EMT) changes in human autosomal dominant polycystic kidney disease (ADPKD) cells.

Venugopal J, McDermott J, Sanchez G, Sharma M, Barbosa L, Reif GA, Wallace DP, Blanco G.

Exp Cell Res. 2017 Jun 15;355(2):142-152. doi: 10.1016/j.yexcr.2017.04.001. Epub 2017 Apr 3.

24.

microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism.

Hajarnis S, Lakhia R, Yheskel M, Williams D, Sorourian M, Liu X, Aboudehen K, Zhang S, Kersjes K, Galasso R, Li J, Kaimal V, Lockton S, Davis S, Flaten A, Johnson JA, Holland WL, Kusminski CM, Scherer PE, Harris PC, Trudel M, Wallace DP, Igarashi P, Lee EC, Androsavich JR, Patel V.

Nat Commun. 2017 Feb 16;8:14395. doi: 10.1038/ncomms14395.

25.

Autocrine IL-10 activation of the STAT3 pathway is required for pathological macrophage differentiation in polycystic kidney disease.

Peda JD, Salah SM, Wallace DP, Fields PE, Grantham CJ, Fields TA, Swenson-Fields KI.

Dis Model Mech. 2016 Sep 1;9(9):1051-61. doi: 10.1242/dmm.024745. Epub 2016 Aug 4.

26.

Adaptation of the State-Trait Inventory for Cognitive and Somatic Anxiety for Use in Children: A Preliminary Analysis.

Deacy AD, Gayes LA, De Lurgio S, Wallace DP.

J Pediatr Psychol. 2016 Oct;41(9):1033-43. doi: 10.1093/jpepsy/jsw030. Epub 2016 Apr 25.

PMID:
27114070
27.

Parent Attitudes Toward Pain Management for Childhood Immunizations.

Connelly M, Wallace DP, Williams K, Parker J, Schurman JV.

Clin J Pain. 2016 Aug;32(8):654-8. doi: 10.1097/AJP.0000000000000327.

PMID:
26710227
28.

MicroRNA-21 Aggravates Cyst Growth in a Model of Polycystic Kidney Disease.

Lakhia R, Hajarnis S, Williams D, Aboudehen K, Yheskel M, Xing C, Hatley ME, Torres VE, Wallace DP, Patel V.

J Am Soc Nephrol. 2016 Aug;27(8):2319-30. doi: 10.1681/ASN.2015060634. Epub 2015 Dec 17.

29.

Phosphodiesterase Isoform Regulation of Cell Proliferation and Fluid Secretion in Autosomal Dominant Polycystic Kidney Disease.

Pinto CS, Raman A, Reif GA, Magenheimer BS, White C, Calvet JP, Wallace DP.

J Am Soc Nephrol. 2016 Apr;27(4):1124-34. doi: 10.1681/ASN.2015010047. Epub 2015 Aug 19.

30.

Ouabain Regulates CFTR-Mediated Anion Secretion and Na,K-ATPase Transport in ADPKD Cells.

Jansson K, Venugopal J, Sánchez G, Magenheimer BS, Reif GA, Wallace DP, Calvet JP, Blanco G.

J Membr Biol. 2015 Dec;248(6):1145-57. doi: 10.1007/s00232-015-9832-7. Epub 2015 Aug 20.

31.

Chloride secretion by renal collecting ducts.

Rajagopal M, Wallace DP.

Curr Opin Nephrol Hypertens. 2015 Sep;24(5):444-9. doi: 10.1097/MNH.0000000000000148.

32.

Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease.

Chen L, Zhou X, Fan LX, Yao Y, Swenson-Fields KI, Gadjeva M, Wallace DP, Peters DJ, Yu A, Grantham JJ, Li X.

J Clin Invest. 2015 Jun;125(6):2399-412. doi: 10.1172/JCI80467. Epub 2015 May 11.

33.

A brief primary care intervention to reduce fear of movement in chronic low back pain patients.

Guck TP, Burke RV, Rainville C, Hill-Taylor D, Wallace DP.

Transl Behav Med. 2015 Mar;5(1):113-21. doi: 10.1007/s13142-014-0292-x.

34.

The role of parent psychological flexibility in relation to adolescent chronic pain: further instrument development.

Wallace DP, McCracken LM, Weiss KE, Harbeck-Weber C.

J Pain. 2015 Mar;16(3):235-46. doi: 10.1016/j.jpain.2014.11.013. Epub 2014 Dec 11.

PMID:
25499065
35.

Amplified pain syndromes in children: treatment and new insights into disease pathogenesis.

Hoffart CM, Wallace DP.

Curr Opin Rheumatol. 2014 Sep;26(5):592-603. doi: 10.1097/BOR.0000000000000097. Review.

PMID:
25010441
36.

Tubular obstruction leads to progressive proximal tubular injury and atubular glomeruli in polycystic kidney disease.

Galarreta CI, Grantham JJ, Forbes MS, Maser RL, Wallace DP, Chevalier RL.

Am J Pathol. 2014 Jul;184(7):1957-66. doi: 10.1016/j.ajpath.2014.03.007. Epub 2014 May 9.

37.

Retinoic acid signaling pathways in development and diseases.

Das BC, Thapa P, Karki R, Das S, Mahapatra S, Liu TC, Torregroza I, Wallace DP, Kambhampati S, Van Veldhuizen P, Verma A, Ray SK, Evans T.

Bioorg Med Chem. 2014 Jan 15;22(2):673-83. doi: 10.1016/j.bmc.2013.11.025. Epub 2013 Nov 22. Review.

38.

Aberrant expression of laminin-332 promotes cell proliferation and cyst growth in ARPKD.

Vijayakumar S, Dang S, Marinkovich MP, Lazarova Z, Yoder B, Torres VE, Wallace DP.

Am J Physiol Renal Physiol. 2014 Mar 15;306(6):F640-54. doi: 10.1152/ajprenal.00104.2013. Epub 2013 Dec 26.

39.

Periostin promotes renal cyst growth and interstitial fibrosis in polycystic kidney disease.

Wallace DP, White C, Savinkova L, Nivens E, Reif GA, Pinto CS, Raman A, Parnell SC, Conway SJ, Fields TA.

Kidney Int. 2014 Apr;85(4):845-54. doi: 10.1038/ki.2013.488. Epub 2013 Nov 27.

40.

Effectiveness of using noncontingent escape for general behavior management in a pediatric dental clinic.

Allen KD, Wallace DP.

J Appl Behav Anal. 2013 Dec;46(4):723-37. doi: 10.1002/jaba.82. Epub 2013 Sep 30.

PMID:
24114693
41.

The role of phospholipase D in modulating the MTOR signaling pathway in polycystic kidney disease.

Liu Y, Käch A, Ziegler U, Ong AC, Wallace DP, Arcaro A, Serra AL.

PLoS One. 2013 Aug 23;8(8):e73173. doi: 10.1371/journal.pone.0073173. eCollection 2013.

42.

Smac-mimetic-induced epithelial cell death reduces the growth of renal cysts.

Fan LX, Zhou X, Sweeney WE Jr, Wallace DP, Avner ED, Grantham JJ, Li X.

J Am Soc Nephrol. 2013 Dec;24(12):2010-22. doi: 10.1681/ASN.2013020176. Epub 2013 Aug 29.

43.

Novel role of ouabain as a cystogenic factor in autosomal dominant polycystic kidney disease.

Blanco G, Wallace DP.

Am J Physiol Renal Physiol. 2013 Sep 15;305(6):F797-812. doi: 10.1152/ajprenal.00248.2013. Epub 2013 Jun 12. Review.

44.

Acceptance of pain: associations with depression, catastrophizing, and functional disability among children and adolescents in an interdisciplinary chronic pain rehabilitation program.

Weiss KE, Hahn A, Wallace DP, Biggs B, Bruce BK, Harrison TE.

J Pediatr Psychol. 2013 Aug;38(7):756-65. doi: 10.1093/jpepsy/jst028. Epub 2013 May 17.

PMID:
23685451
45.

Macrophages promote polycystic kidney disease progression.

Swenson-Fields KI, Vivian CJ, Salah SM, Peda JD, Davis BM, van Rooijen N, Wallace DP, Fields TA.

Kidney Int. 2013 May;83(5):855-64. doi: 10.1038/ki.2012.446. Epub 2013 Feb 20.

46.

Use of video eyewear to manage distress in children during restorative dental treatment.

Hoge MA, Howard MR, Wallace DP, Allen KD.

Pediatr Dent. 2012 Sep-Oct;34(5):378-82.

PMID:
23211912
47.

Evaluation of a behavioral treatment package to reduce sleep problems in children with Angelman Syndrome.

Allen KD, Kuhn BR, DeHaai KA, Wallace DP.

Res Dev Disabil. 2013 Jan;34(1):676-86. doi: 10.1016/j.ridd.2012.10.001. Epub 2012 Nov 1.

PMID:
23123881
48.

Calmodulin-sensitive adenylyl cyclases mediate AVP-dependent cAMP production and Cl- secretion by human autosomal dominant polycystic kidney cells.

Pinto CS, Reif GA, Nivens E, White C, Wallace DP.

Am J Physiol Renal Physiol. 2012 Nov 15;303(10):F1412-24. doi: 10.1152/ajprenal.00692.2011. Epub 2012 Sep 5.

49.

Endogenous concentrations of ouabain act as a cofactor to stimulate fluid secretion and cyst growth of in vitro ADPKD models via cAMP and EGFR-Src-MEK pathways.

Jansson K, Nguyen AN, Magenheimer BS, Reif GA, Aramadhaka LR, Bello-Reuss E, Wallace DP, Calvet JP, Blanco G.

Am J Physiol Renal Physiol. 2012 Oct;303(7):F982-90. doi: 10.1152/ajprenal.00677.2011. Epub 2012 Aug 1.

50.

Protein phosphatase-1α interacts with and dephosphorylates polycystin-1.

Parnell SC, Puri S, Wallace DP, Calvet JP.

PLoS One. 2012;7(6):e36798. doi: 10.1371/journal.pone.0036798. Epub 2012 Jun 4.

Supplemental Content

Loading ...
Support Center